Joint ENTIS-OTIS Meeting 2024 (Nyborg, Denmark): Call for abstracts

Prospective delegates are invited to submit research abstracts for the Joint ENTIS-OTIS Meeting which will be held in Nyborg, Denmark from the 12th to 15th September. The abstract submission deadline is 28th March 2024, and authors will be notified of acceptance by 26th April 2024. Please see here for the abstract submission template and instructions for authors. More information about […]

» Read more

Impact of maternal first trimester valproate treatment regimen on the risk of birth defects

Researchers from TIS Berlin (Embryotox Center of Clinical Teratology and Drug Safety in Pregnancy, Charité РUniversitätsmedizin Berlin) have published an analysis of 484 first trimester valproate exposed pregnancies which investigates the effects of valproate dose and first trimester treatment discontinuation on the risks of spontaneous abortion and major birth defects. More information is available here.

» Read more

In utero cannabis exposure associated with increased risks of fetal growth impairment, preterm birth, and NICU admission

Researchers from the University of California San Francisco have published population-based cohort study using data collected from the Kaiser Permanente Northern California insurance database which has investigated the risk of adverse neonatal outcomes following maternal cannabis use in pregnancy. More information is available here. Photo by Thought Catalog on Unsplash

» Read more
1 2 3 4 5 24